We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Research · May 17, 2022

Omalizumab for Bullous Pemphigoid

Journal of Cutaneous Medicine and Surgery


Additional Info

Journal of Cutaneous Medicine and Surgery
Omalizumab for the Treatment of Bullous Pemphigoid: A Systematic Review of Efficacy and Safety
J Cutan Med Surg 2022 Apr 04;[EPub Ahead of Print], K D'Aguanno, S Gabrielli, L Ouchene, A Muntyanu, M Ben-Shoshan, X Zhang, L Iannattone, E Netchiporouk

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading